MICHAEL BROWN is a Partner at Shield Capital, a Senior Distinguished Fellow at the Institute for Security and Technology, and ...
Disparate pathogenic mechanisms complicate precision-medicine efforts to treat diffuse large B-cell lymphoma (DLBCL), the most common lymphoma diagnosis. Though potentially curable with frontline ...
It was recently discussed on this site how important Tanner Bibee is for the Cleveland Guardians and their 2025 aspirations.